Study: Pharma Companies Often Profit From Donations to Patient Assistance Charities

Pharmaceutical companies often profit from their donations to non-profit patient assistance charities that are intended to help people afford high-cost medications, according to a study published in this month’s edition of the journal Health Affairs.

HHS’s Office of Inspector General (OIG) has provided guidance on the charities and cracked down in recent years on several charities and drug manufacturers. However, the authors noted that “the current regulations or enforcement permit donations that violate the spirit of Medicare’s Anti-Kickback Statute,” which prohibits pharma companies from covering Medicare Advantage enrollees’ out-of-pocket drug spending for the drugs they manufacture.

© 2022 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

an-elderly-sitting-on-a-couch
April 14

CMS Targets Patient-Assistance Programs; Rule Could Curtail Aid

READ MORE
woman-looking-at-pill-bottle
April 14

Many Medicare Enrollees Can’t Afford Cancer, Specialty Drugs

READ MORE
judge-gavel-medication-pills-and-stethoscope-on-rustic-desk
October 1

Insurer Suits Take Aim at ‘Pay for Delay,’ Copay Assistance

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today